Back
 ABB  Vol.4 No.8 B , August 2013
Effects of vacuum-assisted closure and Drotrecogin alpha on inflammatory markers in severe acute pancreatitis
Abstract: In severe acute pancreatitis (SAP) inflammatory processes foster necrosis, cellular lysis and liberation of vasoactive substances associated with multiple organ failure. The effects of vacuum-assisted closure and Drotrecogin alpha on inflammatory cytokines were evaluated in SAP patients with infected necrosis. Methods: Forty-six patients were included in three groups: Group 1, necrosectomy and abdominal cavity washing; Group 2, necrosectomy plus vacuum-assisted closure (VAC), and Group 3, necrossectomy plus VAC plus Drotrecogin alpha. Immunoreactive IL-32, TNF-α, IL-6, TGF-β and IL-2 cytokines were quantified with ELISA method. Results: IL-32 was significantly increased in all patients, predominantly the non-survivor of Group 3 (p < 0.0001). Group 2 maintained increased IL-32 levels throughout. Peak TNF-α was observed in non-survivors of Groups 1 and 2, with a frank tendency to decrease in Group 3. The IL-6 was increased, sustained throughout the study, peaking at the onset in non-survivors. At the end IL-6 tended to diminish, predominantly in survivors. TNF-α and IL-6 were significantly increased on hospitalization, with a maximum peak in non-survivors of all groups. Initial values of TGF-β were significantly increased in survivors of the three groups, and were significantly diminished in non-survivors; affecting pancreas regeneration and favoring systemic inflammation, with possible multiple-organ repercussions. IL-2 levels were elevated, predominantly in non-survivors of Group 1. There was positive correlation between the increase IL-32 and TNF-α, and negative correlation between the increase in TNF-α and decrease in TGF-β; and, a tendency for negative correlation between the IL-2 increased and TGF-β levels. Conclusion: We found a generalized, sustained inflammatory state that fosters a torpid outcome in SAP patients.
Cite this paper: Arias-Carvajal, O. , Hermosillo-Sandoval, J. , Gutiérrez-Martínez, C. , Pacheco-Moisés, F. , Ortiz, G. , Rodríguez-Carrizalez, A. , Román-Pintos, L. and Miranda-Díaz, A. (2013) Effects of vacuum-assisted closure and Drotrecogin alpha on inflammatory markers in severe acute pancreatitis. Advances in Bioscience and Biotechnology, 4, 43-53. doi: 10.4236/abb.2013.48A2007.
References

[1]   Kamer, E., Unalp, H.R., Derici, H., Tansug, T. and Onal, M.A. (2007) Early diagnosis and prediction of severity in acute pancreatitis using the urine trypsinogen-2 dipstick test: A prospective study. World Journal of Gastroenterology, 13, 6208-6212. doi:10.3748/wjg.13.6208

[2]   Bollen, T.L., van Santvoort, H.C., Besselink, M.G., van Leeuwen, M.S., Horvath, K.D., Freeny, P.C., et al. (2008) The Atlanta Classification of acute pancreatitis revisited. British Journal of Surgery, 95, 6-21. doi:10.1002/bjs.6010

[3]   Aoun, E., Chen, J., Reighard, D., Gleeson, F.C., Whitcomb, D.C. and Papachristou, G.I. (2010) Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: A meta-analysis. Pancreatology, 9, 777-785. doi:10.1159/000214191

[4]   Kim, S.H., Han, S.Y., Azam, T., Yoon, D.Y. and Dinarello, C.A. (2005) Interleukin-32: A cytokine and inducer of TNF-alpha. Immunity, 22, 131-142.

[5]   Dambrauskas, Z., Giese, N., Gulbinas, A., Giese, T., Berberat, P.O., Pundzius, J., et al. (2010) Different profiles of cytokine expression during mild and severe acute pancreatitis. World Journal of Gastroenterology, 16, 1845-1853. doi:10.3748/wjg.v16.i15.1845

[6]   Beutler, B. and Cerami, A. (1987) Cachectin: More than a tumor necrosis factor. The New England Journal of Medicine, 316, 379-385. doi:10.1056/NEJM198702123160705

[7]   Zhang, H., Neuhofer, P., Song, L., Rabe, B., Lesina, M., Kurkowski, M.U., et al. (2013) IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. Journal of Clinical Investigation, 123, 1019-1031. doi:10.1172/JCI64931

[8]   Sandoval, D., Gukovskaya, A., Reavy, P., et al. (1996) The role of neutrophils and platelet—Activating factor in mediating experimental pancreatitis. Gastroenterology, 111, 1081-1091.

[9]   Kilciler, G., Musabak, U., Bagci, S., Yesilova, Z., Tuzun, A., Uygun, A., et al. (2008) Do the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis? Clinical and Developmental Immunology, 2008, 481560. doi:10.1155/2008/481560

[10]   Lempinen, M., Stenman, U.H., Finne, P., Puolakkainen, P., Haapiainen, R., Kemppainen, E. (2003) Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. Journal of Surgical Research, 111, 267-273. doi:10.1016/S0022-4804(03)00044-1

[11]   Bucher, P., Pugin, F. and Morel, P. (2008) Minimally invasive necrosectomy for infected necrotizing pancreatitis. Pancreas, 36, 113-119. doi:10.1097/MPA.0b013e3181514c9e

[12]   Besselink, M.G., van Santvoort, H.C., Boermeester, M.A., Nieuwenhuijs, V.B., van Goor, H., Dejong, C.H., et al. (2009) Timing and impact of infections in acutepancreatitis. British Journal of Surgery, 96, 267-273. doi:10.1002/bjs.6447

[13]   Wondberg, D., Larusson, H.J., Metzger, U., Platz, A. and Zingg, U. (2008) Treatment of the open abdomen with the commercially available vacuum-assisted closure system in patients with abdominal sepsis. World Journal of Surgery, 32, 2724-2729. doi:10.1007/s00268-008-9762-y

[14]   Jamdar, S. and Siriwardena, A.K. (2005) Drotrecoginalfa (recombinant human activated protein C) in severe acute pancreatitis. Critical Care, 9, 321-322. doi:10.1186/cc3777

[15]   Pettila, V., Kyhala, L., Kylanpaa, M.L., Leppaniemi, A., Tallgren, M., Markkola, A., et al. (2010) APCAP-activatedprotein C in acutepancreatitis: A double-blind randomized human pilot trial. Critical Care, 14, R139. doi:10.1186/cc9203

[16]   De Campos, T., Cerqueira, C., Kuryura, L., Parreira, J.G., Soldá, S., Perlingeiro, J.A., et al. (2008) Morbimortality indicators in severe acute pancreatitis. JOP, 9, 690-697.

[17]   Cappell, M.S. (2008) Acute pancreatitis: Etiology, clinical presentation, diagnosis, and therapy. Medical Clinics of North America, 92, 889-923. doi:10.1016/j.mcna.2008.04.013

[18]   Nishida, A., Andoh, A., Inatomi, O. and Fujiyama, Y. (2009) Interleukin-32 expression in the pancreas. The Journal of Biological Chemistry, 284, 17868-17876. doi:10.1074/jbc.M900368200

[19]   Heinhuis, B., Koenders, M.I., van den Berg, W.B., Netea, M.G., Dinarello, C.A. and Joosten, L.A. (2012) Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. The Journal of Biological Chemistry, 287, 5733-5743. doi:10.1074/jbc.M111.288290

[20]   Panek, J., Karcz, D., Pieton, R., Zasada, J., Tusinski M., Dolecki, M., et al. (2006) Blood serum levels of proinflammatory cytokines in patients with different degrees of biliary pancreatitis. Canadian Journal of Gastroenterology, 20, 645-648.

[21]   Zhang, H., Patel, S.A., Kandil, E., Mueller, C.M., Lin, Y.Y. and Zenilman, M.E. (2003)Pancreaticelastase is proven to be a mannose-binding protein—Implications for the systemicresponse to pancreatitis. Surgery, 133, 678-688. doi:10.1067/msy.2003.175

[22]   Jaffray, C., Mendez, C., Denham, W., Carter, G. and Norman, J. (2000) Specific pancreatic enzymes activate macrophages to produce tumor necrosis factor-alpha: Role of nuclear factor kappa B and inhibitory kappa B proteins. Journal of Gastrointestinal Surgery, 4, 370-377. doi:10.1016/S1091-255X(00)80015-3

[23]   Mayer, J., Rau, B., Gansauge, F. and Beger, H.G. (2000) Inflammatory mediators in human acutepancreatitis: Clinical and pathophysiological implications. Gut, 47, 546-552. doi:10.1136/gut.47.4.546

[24]   Friess, H., Lu, Z., Riesle, E., Uhl, W., Bründler, A.M., Horvath, L., et al. (1998) Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Annals of Surgery, 227, 95-104. doi:10.1097/00000658-199801000-00014

[25]   Kihara, Y., Tashiro, M., Nakamura, H., Yamaguchi, T., Yoshikawa, H. and Otsuki, M. (2001) Role of TGF-beta1, extracellular matrix, and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats. Pancreas, 23, 288-295. doi:10.1097/00006676-200110000-00010

[26]   Zhang, X., Chez, H., Liu, F. and Zhang, J. (2009) Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis. Journal of Zhejiang University Science B, 10, 493-498. doi:10.1631/jzus.B0820265

[27]   Malek, T.R. (2008) The biology of interleukin-2. Annual Review of Immunology, 26, 453-479. doi:10.1146/annurev.immunol.26.021607.090357

[28]   Fritz, S., Hartwig, W., Lehmann, R., Will-Schweiger, K., Kommerell, M., Hackert, T., et al. (2008) Phrophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Critical Care, 12, R141. doi:10.1186/cc7118

[29]   Heinrich, S., Schafer, M., Rousson, V. and Clavien, P.A. (2006) Evidence-based treatment of acute pancreatitis. A look at established paradigms. Annals of Surgery, 243, 154-168. doi:10.1097/01.sla.0000197334.58374.70

[30]   Wang, X., Cui, Z., Li, H., Saleen, A.F., Zhang, D., Miao, B., et al. (2010) Nosocomial mortality and early prediction of patients with severe acute pancreatitis. Journal of Gastroenterology and Hepatology, 25, 1386-1393. doi:10.1111/j.1440-1746.2010.06376.x

[31]   Pearce, C.B., Gunn, S.R., Ahmed, A. and Johnson, C.D. (2006) Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein. Pancreatology, 6, 123-131. doi:10.1159/000090032

[32]   Perez, D., Wildi, S., Demartines, N., Bramkamp, M., Koehler, C. and Clavien, P.A. (2007) Prospective evaluation of vacuum-assisted closure in abdominal compartment syndrome and severe abdominal sepsis. Journal of the American College of Surgeons, 205, 586-592. doi:10.1016/j.jamcollsurg.2007.05.015

[33]   Labler, L., Mica, L., Harter, L., Trentz, O. and Keel, M. (2006) Influence of VAC therapy on cytokines and growth factors in traumatic wounds. Zentralblatt für Chirurgie, 131, S62-S67. doi:10.1055/s-2006-921511

 
 
Top